Matrix Type Influences the Levels of Soluble Immune Checkpoints
Journal of Clinical Laboratory Analysis, EarlyView.This study aimed to assess whether the quantification of soluble immune checkpoints (sICs) is comparable between serum and EDTA‐plasma samples. We quantified 17 sICs by a multiplex bead‐based assay in paired serum and plasma‐EDTA samples collected from a cohort of 38 healthy subjects.
Veronica Buia +7 more
wiley +1 more source
PB2383: MICROSATELLITE INSTABILITY AND 9P24.1 ALTERATIONS IN HODGKIN LYMPHOMA
, 2023 Ekaterina Tregubova +3 more
openalex +1 more source
Frontiers in the Management of Orthopaedic Periprosthetic Joint Infection
Journal of Orthopaedic Research, EarlyView.ABSTRACT Periprosthetic joint infection (PJI) is a devastating complication of total joint arthroplasty (TJA), one of the most frequently performed surgical procedures worldwide. Management of acute PJI commonly involves debridement, antibiotics, and implant retention (DAIR), though failure rates remain high due to antibiotic‐tolerant biofilms. Chronic
Michael F. Shannon +9 more
wiley +1 more source
Non-Hogkins lymphoma ′masquerading′ as pott′s disease in a 13-year old boy: A case report
Sahel Medical Journal, 2010 Lymphomas are malignant neoplasms of the lymphoid lineage which are broadly classified as either Hodgkin disease or as non-Hodgkin lymphoma (NHL).
O A Adegboye
doaj
Beta - ThrombogloBulin And HA - Platelet Factor 4 In Multiple Myeloma, Hodgkin Disease And Malig - Nant Lymphoma - Effects Of Therapy [PDF]
, 1981 Hans-G. Klingemann +2 more
openalex +1 more source
Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage [PDF]
, 2020 National Cancer Institute
openalex +1 more source
Population Pharmacokinetics and CD20 Binding Dynamics for Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL) [PDF]
, 2023 Brendan C. Bender +13 more
openalex +1 more source
Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review
JEADV Clinical Practice, EarlyView.ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino +3 more
wiley +1 more source
Role of Radiation in Combination With CD30-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Hodgkin Lymphoma [PDF]
, 2023 Colton Ladbury +5 more
openalex +1 more source